Frequency News and Research

RSS

USC's Keck Medicine becomes world's first center to implant responsive brain device to treat epilepsy

On Dec. 18, Keck Medicine of USC became the world's first medical center to implant a responsive brain device newly approved by the Food and Drug Administration to treat epilepsy, with potential to help millions of people worldwide.

20 Dec 2013

FDA approves Baxter's FEIBA for prophylactic treatment of hemophilia patients with inhibitors

Baxter International Inc. today announced that the United States Food and Drug Administration granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only FDA-approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B who have developed inhibitors.

From Baxter International Inc. 20 Dec 2013

Study finds 87% of teens who quit chewing gum experience relief of migraine headache

Teenagers are notorious for chewing a lot of gum. The lip smacking, bubble popping, discarded gum stuck to the sole give teachers and parents a headache.

20 Dec 2013

Australian Therapeutic Goods Administration approves Genzyme's Lemtrada for multiple sclerosis

Genzyme, a Sanofi company, announced today that the Australian Therapeutic Goods Administration has approved Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis for patients with active disease defined by clinical or imaging features to slow the accumulation of physical disability and reduce the frequency of clinical relapses.

19 Dec 2013

Restraint, seclusion in schools are used more frequently on students with disability

The restraint and seclusion of students in U.S. public schools in response to student behavior problems are used much more frequently on students with a disability than on students without a disability, and especially in affluent school districts, according to new research at the Carsey Institute at the University of New Hampshire.

18 Dec 2013

Studies offer new insight into diverticulosis

Diverticulosis, a condition that develops when pouches form in the wall of the colon, is increasing in frequency. It affects the majority of those reaching the age of 80 - a growing portion of the population - and imposes a substantial burden on health-care resources, but curiously there is a lack of data and unanswered questions around this condition.

18 Dec 2013

Unexpected toxicity of pazopanib/pemetrexed in NSCLC halts study

A phase II study comparing first-line combination pazopanib/pemetrexed chemotherapy with the standard cisplatin/pemetrexed treatment in non-small-cell lung cancer was terminated early owing to an increased frequency of adverse events in the experimental arm.

17 Dec 2013

New report shows death rates for lung cancer dropping at a faster pace

The Annual Report to the Nation on the Status of Cancer, covering the period 1975, showed death rates for lung cancer, which accounts for more than one in four cancer deaths, dropping at a faster pace than in previous years. The recent larger drop in lung cancer deaths is likely the result of decreased cigarette smoking prevalence over many years, and is now being reflected in mortality trends. The lung cancer death rate decline, as well as declines in colorectal, breast, and prostate cancer death rates, has also helped drive decreases in death rates for all cancers types combined, a trend that began about 20 years ago.

17 Dec 2013

Research on neurofeedback training proves to improve attention, working memory performance

The Distinguished Professor Shu-Lan Hsieh's research on neurofeedback training has proven to improve attention and working memory performance, National Cheng Kung University revealed recently.

17 Dec 2013

U-M researchers report novel approach for treating tinnitus in humans

For tens of millions of Americans, there's no such thing as the sound of silence. Instead, even in a quiet room, they hear a constant ringing, buzzing, hissing, humming or other noise in their ears that isn't real. Called tinnitus, it can be debilitating and life-altering.

17 Dec 2013

Data show that HCV genotype-1 infected patients may benefit from faldaprevir

Data show that Boehringer Ingelheim’s second-generation protease inhibitor faldaprevir, when used in combination with pegylated interferon and ribavirin, was effective even with the presence of naturally-occurring mutant variants of the hepatitis C virus, such as the NS3 Q80K polymorphism

16 Dec 2013

Research roundup: Long-term care use varies dramatically by state; health spending slowdown explained

In 2012, about 58,500 paid, regulated long-term care services providers served about 8 million people in the United States. Long-term care services were provided by 4,800 adult day services centers, 12,200 home health agencies, 3,700 hospices, 15,700 nursing homes, and 22,200 assisted living and similar residential care communities. Each day in 2012, there were 273,200 participants enrolled in adult day services centers, 1,383,700 residents in nursing homes, and 713,300 residents in residential care communities; in 2011, about 4,742,500 patients received services from home health agencies, and 1,244,500 patients received services from hospices. Provider sectors differed in ownership, and average size and supply varied by region (Harris-Kojetin et al., 12/12).

16 Dec 2013

Gilead Sciences gets FDA approval for once-daily single tablet HIV-1 regimen Complera

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved the single tablet HIV-1 regimen Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) for use in certain virologically-suppressed (HIV RNA <50 copies/mL) adult patients on a stable antiretroviral regimen in order to replace their current antiretroviral treatment regimen. Complera was first approved in 2011 for patients new to therapy and is now one of the most widely-prescribed HIV regimens in the United States.

13 Dec 2013

Indegene’s MCM division launches Brand-Focused Solutions for brand marketing teams

Indegene, a leading provider of R&D, commercial, and marketing solutions to top global pharmaceutical and healthcare organizations, today announced that its Multi-channel Marketing (MCM) division has launched a suite of Brand-Focused Solutions for the brand marketing teams.

13 Dec 2013

Cardiac patients can benefit from home-based high intensity training

Cardiac patients can benefit from home-based high intensity training, even without the support of fancy training equipment or a clinic, new research from the Norwegian University of Science and Technology has shown.

13 Dec 2013

NeuroPace- Responsive Neurostimulation System treatment to be offered at Spectrum Health

Spectrum Health will be the first health system in West Michigan and among the first in the nation to offer treatment with a newly FDA-approved device that uses electric stimulation of the brain for adult epilepsy patients whose seizures have not responded to medication.

13 Dec 2013

Bioethics Commission releases ethical recommendations to manage incidental and secondary findings

Researchers conduct a memory study, scan a participant's brain, and find more than they bargain for: a tumor. What do the researchers owe the participant? What does the participant want to know?

13 Dec 2013

Airway alterations present even in young smokers without COPD

A study has found functional and inflammatory changes in the nasal and lower airways of young, healthy smokers in the absence of pulmonary function decline.

12 Dec 2013

Climate differences drive gene changes, find Virginia Bioinformatics Institute researchers

Interplay between genes and the environment has been pondered at least since the phrase "nature versus nurture" was coined in the mid-1800s.

12 Dec 2013

New algorithm separates signals into individual frequencies using minimal number of samples

The fast Fourier transform, one of the most important algorithms of the 20th century, revolutionized signal processing. The algorithm allowed computers to quickly perform Fourier transforms - fundamental operations that separate signals into their individual frequencies - leading to developments in audio and video engineering and digital data compression.

12 Dec 2013

Frequency News and Research

USC's Keck Medicine becomes world's first center to implant responsive brain device to treat epilepsy

FDA approves Baxter's FEIBA for prophylactic treatment of hemophilia patients with inhibitors

Study finds 87% of teens who quit chewing gum experience relief of migraine headache

Australian Therapeutic Goods Administration approves Genzyme's Lemtrada for multiple sclerosis

Restraint, seclusion in schools are used more frequently on students with disability

Studies offer new insight into diverticulosis

Unexpected toxicity of pazopanib/pemetrexed in NSCLC halts study

New report shows death rates for lung cancer dropping at a faster pace

Research on neurofeedback training proves to improve attention, working memory performance

U-M researchers report novel approach for treating tinnitus in humans

Data show that HCV genotype-1 infected patients may benefit from faldaprevir

Research roundup: Long-term care use varies dramatically by state; health spending slowdown explained

Gilead Sciences gets FDA approval for once-daily single tablet HIV-1 regimen Complera

Indegene’s MCM division launches Brand-Focused Solutions for brand marketing teams

Cardiac patients can benefit from home-based high intensity training

NeuroPace- Responsive Neurostimulation System treatment to be offered at Spectrum Health

Bioethics Commission releases ethical recommendations to manage incidental and secondary findings

Airway alterations present even in young smokers without COPD

Climate differences drive gene changes, find Virginia Bioinformatics Institute researchers

New algorithm separates signals into individual frequencies using minimal number of samples

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News